Prudential Financial Inc Ironwood Pharmaceuticals Inc Transaction History

Prudential Financial Inc

  • $80 Billion
  • Q3 2025

A detailed history of Prudential Financial Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Prudential Financial Inc holds 49,935 shares of IRWD stock, worth $168,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,935
Previous 20,635 141.99%
Holding current value
$168,280
Previous $14,000 364.29%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$0.69 - $1.46 $20,217 - $42,778
29,300 Added 141.99%
49,935 $65,000
Q2 2025

Aug 12, 2025
BUY
$0.57 - $1.44 $5,046 - $12,749
8,854 Added 75.15%
20,635 $14,000
Q1 2025

May 13, 2025
SELL
$1.41 - $4.58 $188,667 - $612,836
-133,807 Reduced 91.91%
11,781 $17,000
Q4 2024

Feb 11, 2025
SELL
$3.34 - $5.04 $17,368 - $26,208
-5,200 Reduced 3.45%
145,588 $644,000
Q3 2024

Nov 13, 2024
SELL
$3.93 - $7.04 $12,379 - $22,176
-3,150 Reduced 2.05%
150,788 $619,000
Q2 2024

Aug 13, 2024
SELL
$5.58 - $8.61 $14,061 - $21,697
-2,520 Reduced 1.61%
153,938 $1 Million
Q1 2024

May 14, 2024
SELL
$8.32 - $15.45 $17,280 - $32,089
-2,077 Reduced 1.31%
156,458 $1.36 Million
Q4 2023

Feb 13, 2024
SELL
$8.79 - $11.51 $26,000 - $34,046
-2,958 Reduced 1.83%
158,535 $1.81 Million
Q3 2023

Nov 13, 2023
SELL
$8.25 - $11.35 $95,411 - $131,262
-11,565 Reduced 6.68%
161,493 $1.56 Million
Q2 2023

Aug 11, 2023
BUY
$10.1 - $11.6 $425,735 - $488,963
42,152 Added 32.2%
173,058 $1.84 Million
Q1 2023

May 12, 2023
SELL
$10.37 - $12.56 $44,487 - $53,882
-4,290 Reduced 3.17%
130,906 $1.38 Million
Q4 2022

Feb 14, 2023
SELL
$9.9 - $12.43 $10,008 - $12,566
-1,011 Reduced 0.74%
135,196 $0
Q3 2022

Nov 04, 2022
SELL
$10.14 - $12.38 $204,777 - $250,014
-20,195 Reduced 12.91%
136,207 $1.57 Million
Q2 2022

Aug 15, 2022
BUY
$11.05 - $12.72 $1.33 Million - $1.53 Million
120,575 Added 336.55%
156,402 $1.88 Million
Q1 2022

May 13, 2022
SELL
$10.61 - $12.88 $5.27 Million - $6.4 Million
-497,102 Reduced 93.28%
35,827 $450,000
Q4 2021

Feb 14, 2022
SELL
$10.86 - $13.95 $3.57 Million - $4.59 Million
-328,710 Reduced 38.15%
532,929 $6.21 Million
Q3 2021

Nov 15, 2021
BUY
$11.92 - $13.92 $2.22 Million - $2.6 Million
186,469 Added 27.62%
861,639 $11.3 Million
Q2 2021

Aug 16, 2021
BUY
$10.16 - $13.11 $6.7 Million - $8.65 Million
659,810 Added 4295.64%
675,170 $8.69 Million
Q1 2021

May 12, 2021
BUY
$9.04 - $11.86 $13,180 - $17,291
1,458 Added 10.49%
15,360 $172,000
Q4 2020

Feb 16, 2021
SELL
$9.05 - $12.2 $75,386 - $101,626
-8,330 Reduced 37.47%
13,902 $158,000
Q3 2020

Nov 16, 2020
BUY
$8.99 - $10.74 $76,774 - $91,719
8,540 Added 62.37%
22,232 $200,000
Q2 2020

Aug 12, 2020
BUY
$9.14 - $11.97 $8,737 - $11,443
956 Added 7.51%
13,692 $141,000
Q1 2020

May 12, 2020
BUY
$8.58 - $14.01 $3,363 - $5,491
392 Added 3.18%
12,736 $128,000
Q4 2019

Feb 11, 2020
SELL
$8.22 - $14.0 $15,289 - $26,040
-1,860 Reduced 13.09%
12,344 $164,000
Q3 2019

Nov 13, 2019
BUY
$8.59 - $10.96 $687 - $876
80 Added 0.57%
14,204 $122,000
Q2 2019

Aug 08, 2019
BUY
$9.8 - $12.89 $12,152 - $15,983
1,240 Added 9.62%
14,124 $0
Q1 2019

May 15, 2019
SELL
$8.27 - $12.73 $9,841 - $15,148
-1,190 Reduced 8.46%
12,884 $0
Q4 2018

Feb 07, 2019
SELL
$7.8 - $16.13 $546 - $1,129
-70 Reduced 0.49%
14,074 $122,000
Q3 2018

Nov 07, 2018
SELL
$14.31 - $17.65 $10,589 - $13,060
-740 Reduced 4.97%
14,144 $0
Q2 2018

Aug 13, 2018
BUY
$11.83 - $16.2 $6,033 - $8,262
510 Added 3.55%
14,884 $0
Q4 2017

Feb 13, 2018
SELL
$12.16 - $14.58 $2,310 - $2,770
-190 Reduced 1.3%
14,374 $215,000
Q3 2017

Nov 02, 2017
BUY
$12.07 - $14.87 $175,787 - $216,566
14,564
14,564 $230,000

Others Institutions Holding IRWD

# of Institutions
184
Shares Held
154M
Call Options Held
11.2M
Put Options Held
0
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $516M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email